10 leading foreign companies’ prescription drugs sales top 152 billion won in May

Published: 2011-06-20 07:00:00

Updated: 2011-06-20 07:00:00

The combined sales of 10 multinational firms in Korea posted 152 billion won in May, up 13.4 percent compared with the same month in 2010, according to Ubist and market analysts.

Sales of Korea’s total prescription drugs market in May rose 9.7 percent on-year in May, the highest increase since...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK